RxDoctor Payments Data

Emily Perrotto, APRN

Psychiatric/Mental Health · Mt Juliet, TNNPI 1376134288

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 554 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 58 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,928in general payments, 2019–2025

Across 554 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Alkermes, Inc.$799
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$555
  • Otsuka America Pharmaceutical, Inc.$519
  • Vanda Pharmaceuticals Inc.$463
  • Neurocrine Biosciences, Inc.$452
  • plus $5K from 52 others

What the payments were for

  • Food & beverage$9,928100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie161$2,250
Alkermes, Inc.41$799
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)29$555
Otsuka America Pharmaceutical, Inc.29$519
Vanda Pharmaceuticals Inc.24$463
Neurocrine Biosciences, Inc.18$452
Axsome Therapeutics, Inc.25$421
AstraZeneca(2 entities)15$393
Lilly USA, LLC17$323
Pfizer16$319
Biogen15$313
Teva Pharmaceuticals USA, Inc.19$264
Eisai Inc.14$259
TG Therapeutics, Inc.11$251
Lundbeck LLC11$246
EMD Serono, Inc.11$210
SK Life Science, Inc.5$113
Banner Life Sciences, LLC5$101
Biohaven Pharmaceutical Holding Company Ltd.4$100
Corium, LLC4$98
Upsher-smith Laboratories LLC5$80
Avion Pharmaceuticals4$76
CSL Behring4$73
Takeda Pharmaceuticals U.S.A., Inc.5$72
Noven Therapeutics, LLC4$66
Amgen3$66
Neos Therapeutics, LP3$62
Novo Nordisk3$61
Supernus Pharmaceuticals, Inc.4$59
Catalyst Pharmaceuticals, Inc.3$55
Biohaven Pharmaceuticals, Inc.3$54
Avanir Pharmaceuticals, Inc.2$50
Amarin Pharma, Inc.3$49
Acadia Pharmaceuticals Inc2$43
Almatica Pharma LLC2$42
Jazz Pharmaceuticals Inc.2$42
Amneal Pharmaceuticals LLC2$41
UCB, Inc.1$34
Grifols USA, LLC2$33
Argenx US, Inc.1$33
Adlon Therapeutics L.p.2$32
Collegium Pharmaceutical, Inc.2$30
Neurelis, Inc.2$29
E.r. Squibb & Sons, L.L.C.1$27
Currax Pharmaceuticals LLC2$26
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$24
Scilex Pharmaceuticals Inc.1$23
Dexcom, Inc.1$22
Ironshore Pharmaceuticals Inc.1$20
Johnson & Johnson1$20
Idorsia Pharmaceuticals US Inc1$19
GSK1$18
Bausch Health US, LLC1$18
Sage Therapeutics, LLC1$18
Arbor Pharmaceuticals, Inc.1$17
Zealand Pharma US, Inc.1$15
CMP Pharma, Inc.1$15
Merck1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,928 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$29,859
Medicare patients
46
Services billed
417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl36$60,227
AuvelityDextromethorphan Hbr/Bupropion36$39,125
BelsomraSuvorexant40$16,984
Desvenlafaxine Succinate ErDesvenlafaxine Succinate99$7,788
Aripiprazole40$5,447
Bupropion XlBupropion Hcl56$2,860
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine61$1,821
Fluvoxamine Maleate24$1,728
Clonazepam204$1,619
Duloxetine Hcl56$1,507
Buspirone Hcl55$1,209
Lamotrigine75$1,082
Vilazodone Hcl11$1,016
Alprazolam110$925
Doxepin Hcl14$749

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$2,250$60,22736 claims
Axsome Therapeutics, Inc.Auvelity$421$39,12536 claims
MerckBelsomra$14$16,98440 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Mt Juliet

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →